Influence of Renal Impairment and Genetic Subtypes on Warfarin Control in Japanese Patients
The genotypes of vitamin K epoxide reductase complex 1 (<i>VKORC1</i>) and cytochrome P450 2C9 (<i>CYP2C9</i>) can influence therapeutic warfarin doses. Conversely, nongenetic factors, especially renal function, are associated with warfarin maintenance doses; however, the opt...
Main Authors: | Tomotaka Tanaka, Masafumi Ihara, Kazuki Fukuma, Haruko Yamamoto, Kazuo Washida, Shunsuke Kimura, Akiko Kada, Shigeki Miyata, Toshiyuki Miyata, Kazuyuki Nagatsuka |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Genes |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4425/12/10/1537 |
Similar Items
-
The Effect of CYP2C9 and VKORC1 Genetic Polymorphism on Warfarin Dose Requirements in a Sample of Iraqi Patients
by: Maha Ali Saleh, et al.
Published: (2021-03-01) -
Warfarin Pharmacogenetics: Challenges and Opportunities for Clinical Translation
by: Nita A Limdi, et al.
Published: (2012-10-01) -
Effect of Gene-Based Warfarin Dosing on Anticoagulation Control and Clinical Events in a Real-World Setting
by: Jinhua Zhang, et al.
Published: (2020-01-01) -
Pharmacogenetic Warfarin Dosing Algorithm in the Russian Population
by: T. A. Bairova, et al.
Published: (2019-07-01) -
Should We Routinely Screen for Warfarin Gene Polymorphism in Patients with Coumadin Overdose?
by: Enes Elvin Gül, et al.
Published: (2016-12-01)